| ERIS Lifesciences Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 540596 |
NSE Symbol : ERIS |
P/E(TTM) : 93.14 |
|
ISIN Demat : INE406M01024 |
Div & Yield% : - |
EPS(TTM) : 15.14 |
|
Book Value(₹) : 185.48 |
Market Cap(₹Cr) : 19,189.53 |
Face Value(₹) : 1.00 |
| Mar '24 | Mar '23 | Mar '22 | Mar '21 | Mar '20 | |
|---|---|---|---|---|---|
| SOURCES OF FUNDS : | |||||
| Equity Share Capital | 13.60 | 13.60 | 13.59 | 13.58 | 13.58 |
| Reserves | 2,510.42 | 2,208.29 | 1,904.51 | 1,561.89 | 1,286.12 |
| Equity Share Warrants | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Application Money | 0.00 | 0.00 | 0.45 | 0.00 | 0.00 |
| Total Shareholders Funds | 2,524.02 | 2,221.89 | 1,918.55 | 1,575.47 | 1,299.70 |
| Secured Loans | 1,457.84 | 316.87 | 0.00 | 0.00 | 0.00 |
| Unsecured Loans | 1,071.61 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Debt | 2,529.45 | 316.87 | 0.00 | 0.00 | 0.00 |
| Other Liabilities | 77.83 | 68.53 | 65.62 | 34.88 | 33.99 |
| Total Liabilities | 5,131.30 | 2,607.29 | 1,984.17 | 1,610.35 | 1,333.69 |
| APPLICATION OF FUNDS : | |||||
| Gross Block | 1,811.19 | 1,094.83 | 778.40 | 716.88 | 695.65 |
| Less: Accumulated Depreciation | 295.64 | 197.02 | 136.40 | 132.55 | 95.01 |
| Less:Impairment of Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Block | 1,515.55 | 897.81 | 642.00 | 584.33 | 600.64 |
| Lease Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Capital Work in Progress | 0.61 | 0.34 | 2.98 | 1.56 | 4.37 |
| Investments | 1,618.95 | 996.52 | 777.72 | 531.37 | 320.30 |
| Current Assets, Loans & Advances | |||||
| Inventories | 91.64 | 63.70 | 84.79 | 64.85 | 65.46 |
| Sundry Debtors | 239.97 | 229.22 | 137.56 | 113.76 | 140.82 |
| Cash and Bank Balance | 1,296.74 | 47.65 | 46.11 | 32.66 | 64.95 |
| Loans and Advances | 248.21 | 181.50 | 212.02 | 161.98 | 104.09 |
| Total Current Assets | 1,876.55 | 522.07 | 480.47 | 373.24 | 375.32 |
| Less : Current Liabilities and Provisions | |||||
| Current Liabilities | 175.58 | 114.10 | 123.38 | 110.08 | 114.34 |
| Provisions | 42.68 | 62.27 | 42.86 | 34.38 | 35.10 |
| Total CL & Provisions | 218.27 | 176.37 | 166.24 | 144.46 | 149.44 |
| Net Current Assets | 1,658.29 | 345.70 | 314.23 | 228.78 | 225.89 |
| Miscellaneous Expenses not written off | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax Assets | 485.08 | 399.14 | 350.70 | 297.27 | 240.62 |
| Deferred Tax Liability | 181.30 | 125.36 | 114.59 | 100.52 | 76.46 |
| Net Deferred Tax | 303.78 | 273.78 | 236.11 | 196.75 | 164.16 |
| Other Assets | 34.12 | 93.13 | 11.14 | 67.58 | 18.33 |
| Total Assets | 5,131.31 | 2,607.29 | 1,984.19 | 1,610.36 | 1,333.69 |
| Contingent Liabilities | 332.46 | 630.39 | 24.34 | 18.32 | 15.81 |